Risk factors and outcomes for patients with vascular disease and serious bleeding events

Mark J Alberts1, Deepak L Bhatt, Sidney C Smith

  • 1Department of Neurology, Northwestern University Feinberg School of Medicine, 710N Lake Shore Drive, Room 1420, Chicago, IL 60611, USA. m-alberts@northwestern.edu

Insights

Serious bleeding events in patients with atherosclerotic vascular disease are uncommon but linked to higher risks of major vascular events. Key predictors of bleeding include age, smoking, and certain medications.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Epidemiology

Background:

  • Atherosclerotic vascular disease (ASVD) affects a large population, necessitating understanding of associated risks.
  • Serious bleeding is a known complication, but its precise incidence and impact in ASVD patients require further elucidation.

Purpose of the Study:

  • To investigate the incidence and outcomes of serious bleeding events in a large cohort of patients with ASVD or risk factors.
  • To identify predictors of serious bleeding and its association with subsequent major vascular events.

Main Methods:

  • Prospective observational study of 68,375 outpatients with prior ischemic vascular events or multiple atherosclerotic risk factors.
  • Follow-up data for 64,977 patients, with main outcome measures including rates of serious bleeding and 1-year outcomes.

Main Results:

  • The 1-year incidence of serious hemorrhage was 0.92% (cerebral hemorrhage 0.11%).
  • Patients with symptomatic ASVD had higher hemorrhage rates (1.0%) than those with risk factors only (0.59%).
  • Predictors included age, smoking, hypertension, diabetes, heart failure, antithrombotics, and polyvascular disease. Anticoagulant and dual antiplatelet/anticoagulant use significantly increased bleeding risk.
  • Serious bleeding (excluding cerebral) was associated with a >3-fold increased risk of major vascular outcomes (myocardial infarction, stroke, vascular death).

Conclusions:

  • Serious bleeding complications in ASVD patients are relatively rare but carry significant implications due to the large at-risk population.
  • Bleeding predictors overlap with those for ischemic events, highlighting shared risk factors.
  • Experiencing a serious bleed substantially elevates the risk of major vascular events, underscoring the need for careful risk-benefit assessment in treatment strategies.
Abstract

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...